These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 21236680)

  • 1. The justification for recombinant human bone morphogenetic protein-2 use in one- or two-level lumbar spine interbody fusions.
    Smoljanovic T; Josipovic M; Bojanic I
    J Clin Neurosci; 2011 Mar; 18(3):445-6. PubMed ID: 21236680
    [No Abstract]   [Full Text] [Related]  

  • 2. Accelerating lumbar fusions by combining rhBMP-2 with allograft bone: a prospective analysis of interbody fusion rates and clinical outcomes.
    Slosar PJ; Josey R; Reynolds J
    Spine J; 2007; 7(3):301-7. PubMed ID: 17482113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent article by Shields et al titled "adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion".
    Bennett M; Reynolds AS; Dickerman RD
    Spine (Phila Pa 1976); 2006 Aug; 31(17):2029-30. PubMed ID: 16924224
    [No Abstract]   [Full Text] [Related]  

  • 4. Pseudomorbidity in iliac crest bone graft harvesting: the rise of rhBMP-2 in short-segment posterior lumbar fusion.
    Carragee EJ; Bono CM; Scuderi GJ
    Spine J; 2009 Nov; 9(11):873-9. PubMed ID: 19850231
    [No Abstract]   [Full Text] [Related]  

  • 5. Posterolateral lumbar spine fusion with INFUSE bone graft.
    Glassman SD; Carreon L; Djurasovic M; Campbell MJ; Puno RM; Johnson JR; Dimar JR
    Spine J; 2007; 7(1):44-9. PubMed ID: 17197332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of rhBMP-2 for posterolateral lumbar fusion in smokers.
    Glassman SD; Dimar JR; Burkus K; Hardacker JW; Pryor PW; Boden SD; Carreon LY
    Spine (Phila Pa 1976); 2007 Jul; 32(15):1693-8. PubMed ID: 17621221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of bone morphogenetic protein-2 in mature adults: posterolateral non-instrument-assisted lumbar decompression and fusion.
    Hamilton DK; Jones-Quaidoo SM; Sansur C; Shaffrey CI; Oskouian R; Jane JA
    Surg Neurol; 2008 May; 69(5):457-61; discussion 461-2. PubMed ID: 18207557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human bone morphogenetic protein-2-induced radiculitis in elective minimally invasive transforaminal lumbar interbody fusions: a series review.
    Mindea SA; Shih P; Song JK
    Spine (Phila Pa 1976); 2009 Jun; 34(14):1480-4; discussion 1485. PubMed ID: 19525840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Administration of human recombinant bone morphogenetic protein-2 for spine fusion may be associated with transient postoperative renal insufficiency.
    Latzman JM; Kong L; Liu C; Samadani U
    Spine (Phila Pa 1976); 2010 Apr; 35(7):E231-7. PubMed ID: 20228696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re: Dimar JR, Glassman SD, Burkus KJ, et al. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft. Spine 2006; 31:2534-40.
    Gill JB
    Spine (Phila Pa 1976); 2007 Mar; 32(6):708; author reply 708. PubMed ID: 17413480
    [No Abstract]   [Full Text] [Related]  

  • 11. rhBMP-2 enhancement of posterolateral spinal fusion in a rabbit model in the presence of concurrently administered doxorubicin.
    Singh K; Smucker JD; Ugbo JL; Tortolani PJ; Tsai L; Fei Q; Kuh S; Rumi M; Heller JG; Boden SD; Yoon ST
    Spine J; 2007; 7(3):326-31. PubMed ID: 17482116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathologic inflammatory response induced by recombinant bone morphogenetic protein-2 causing radiculopathy after transforaminal lumbar interbody fusion.
    Muchow RD; Hsu WK; Anderson PA
    Spine J; 2010 Sep; 10(9):e1-6. PubMed ID: 20797648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft.
    Dimar JR; Glassman SD; Burkus KJ; Carreon LY
    Spine (Phila Pa 1976); 2006 Oct; 31(22):2534-9; discussion 2540. PubMed ID: 17047540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis.
    Crawford CH; Carreon LY; McGinnis MD; Campbell MJ; Glassman SD
    Spine (Phila Pa 1976); 2009 Jun; 34(13):1390-4. PubMed ID: 19440166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Marshall R. Urist Young Investigator Award. Gene expression during autograft lumbar spine fusion and the effect of bone morphogenetic protein 2.
    Morone MA; Boden SD; Hair G; Martin GJ; Racine M; Titus L; Hutton WC
    Clin Orthop Relat Res; 1998 Jun; (351):252-65. PubMed ID: 9646769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of posterior interbody fusions of the lumbar spine using rhBMP-2.
    Smoljanovic T; Bojanic I; Vlahovic Z
    J Spinal Disord Tech; 2010 Feb; 23(1):78. PubMed ID: 20134288
    [No Abstract]   [Full Text] [Related]  

  • 17. Is it safe to use recombinant human bone morphogenetic protein in posterior cervical fusion?
    Hiremath GK; Steinmetz MP; Krishnaney AA
    Spine (Phila Pa 1976); 2009 Apr; 34(9):885-9. PubMed ID: 19531997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of recombinant human bone morphogenetic protein-2 to enhance posterior cervical spine fusion at 2 years of age: technical note.
    Oluigbo CO; Solanki GA
    Pediatr Neurosurg; 2008; 44(5):393-6. PubMed ID: 18703886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cantilever TLIF with structural allograft and RhBMP2 for correction and maintenance of segmental sagittal lordosis: long-term clinical, radiographic, and functional outcome.
    Anand N; Hamilton JF; Perri B; Miraliakbar H; Goldstein T
    Spine (Phila Pa 1976); 2006 Sep; 31(20):E748-53. PubMed ID: 16985443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Six-year outcomes of anterior lumbar interbody arthrodesis with use of interbody fusion cages and recombinant human bone morphogenetic protein-2.
    Smoljanovic T; Siric F; Bojanic I
    J Bone Joint Surg Am; 2010 Nov; 92(15):2614-5; author reply 2615-6. PubMed ID: 21048181
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.